← All trials
NCT06473948
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 10, 2024
- Primary completion
- Sep 24, 2024
- Completion date
- Feb 27, 2025
- First posted
- Jun 25, 2024
- Last posted
- Jun 25, 2024
- Enrollment
- 27
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- JemincareLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.